Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by KCNN4 is part of a potentially heterotetrameric voltage-independent potassium channel that is activated by intracellular calcium. Additionally we are shipping KCNN4 Proteins (3) and many more products for this protein.
Showing 10 out of 71 products:
Cow (Bovine) Polyclonal KCNN4 Primary Antibody for WB - ABIN2776147
Gao, Chotoo, Balut, Sun, Bailey, Devor: Role of S3 and S4 transmembrane domain charged amino acids in channel biogenesis and gating of KCa2.3 and KCa3.1. in The Journal of biological chemistry 2008
Human Polyclonal KCNN4 Primary Antibody for WB - ABIN948055
Wong, Roberts, Randall: Sex differences in endothelial function in porcine coronary arteries: a role for H2O2 and gap junctions? in British journal of pharmacology 2014
Blockade of K(Ca)3.1 by delivery of TRAM (show TRAM1 Antibodies)-34 via balloon catheter prevented smooth muscle phenotypic modulation and limited subsequent restenosis in a swine model.
KCa3.1 and CFTR (show CFTR Antibodies) colocalize at the plasma membrane.
KCNN4 inhibition differentially regulates migration of intestinal epithelial cells in inflamed vs. non-inflamed conditions in a PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies)-mediated manner.
KCa3.1 protein expression was increased in asthmatic compared to healthy airway epithelium in situ, and KCa3.1 currents were larger in asthmatic compared to healthy HBECs cultured in vitro
Data show that calcium-dependent potassium channel (show KCNAB2 Antibodies) KCa3.1 operates as a positive feedback mechanism for intracellular Ca2 (show CA2 Antibodies)+ increase.
high KCa3.1-mRNA expression levels were indicative of low disease specific survival of ccRCC patients, short progression-free survival, and a high metastatic potential. Therefore, KCa3.1 is of prognostic value in ccRCC
KCa3.1 activation in human lung mast cells is highly dependent on Ca(2 (show CA2 Antibodies)+) influx through Orai1 (show ORAI1 Antibodies) channels, mediated via a close spatiotemporal interaction between the two channels.
describes patients from 2 well-phenotyped hereditary xerocytosis (HX) kindreds, including from one of the first HX kindreds described, who lack predicted heterozygous PIEZO1 (show PIEZO1 Antibodies)-linked variants
Ca2 (show CA2 Antibodies)+- and KCa3.1-dependent processes facilitate "constitutive" alpha smooth muscle actin (show ACTG2 Antibodies) expression and Smad2 (show SMAD2 Antibodies)/3 signalling in IPF-derived fibroblasts, and thus promote fibroblast to myofibroblast differentiation.
The role and mechanisms of KCa3.1 in progressive diabetic chronic kidney disease are reviewed.
The present study shows that KCNN4 is expressed at the mRNA and protein level in RA-SFs, is functionally active, and has a regulatory impact on cell proliferation and secretion of pro-inflammatory and pro-destructive mediators.
Blood brain barrier endothelial cells exhibit KCa3.1 protein and activity.
Modulation of PKA and PI3KC2beta activity to control of KCa3.1 channel expression can be an alternative important target to attenuate ascending thoracic aortic aneurysms in Fabry disease.
These findings suggest that the KCa3.1 channel can serve as a new target to attenuate and prevent development of ascending thoracic aortic aneurysm in Fabry disease.
NDPKB/SK4 signaling is required for neointima formation in injured carotid arteries.
KCa (show CSN3 Antibodies) 3.1 blockade strongly reduced the growth of xenografted NSCLC cells.
The data suggest that the P2Y2 (show P2RY2 Antibodies)/4 receptor activation elicits blood pressure responses via distinct mechanisms involving KCa3.1 and Cx37 (show GJA4 Antibodies).
Overexpression of CCL20 (show CCL20 Antibodies) in human proximal tubular cells is inhibited by blockade of KCa3.1 under diabetic conditions through inhibition of the NF-kappaB (show NFKB1 Antibodies) pathway.
Studies suggest an important modulatory role for KCa3.1 in adult neuroblast migration that could be capitalized on in future attempts to alter the intrinsic repair response of the brain using neuronal precursor cells
Role of the K(Ca)3.1 K+ channel (show KCNC4 Antibodies) in auricular lymph node CD4 (show CD4 Antibodies)+ T-lymphocyte function of the delayed-type hypersensitivity model
Pulmonary hypertension in wild type mice and animals with genetic deficit in KCa2.3 (show KCNN3 Antibodies) and KCa3.1 channels
blockade of KCa3.1 attenuates diabetic renal interstitial fibrogenesis through inhibiting activation of fibroblasts
The protein encoded by this gene is part of a potentially heterotetrameric voltage-independent potassium channel that is activated by intracellular calcium. Activation is followed by membrane hyperpolarization, which promotes calcium influx. The encoded protein may be part of the predominant calcium-activated potassium channel in T-lymphocytes. This gene is similar to other KCNN family potassium channel genes, but it differs enough to possibly be considered as part of a new subfamily.
intermediate conductance calcium-activated potassium channel protein 4
, intermediate-conductance calcium-activated potassium channel
, intermediate conductance calcium-activated potassium channel protein 1
, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
, intermediate conductance calcium-activated potassium channel protein 4-like
, SKCa 4
, putative Gardos channel
, putative erythrocyte intermediate conductance calcium-activated potassium Gardos channel
, intermediate conductance K channel
, intermediate-conductance Ca-activated K channel
, potassium intermediate-small conductance calcium-activated channel subfamily N member 4